Cycloserine is a cyclic amino acid antibiotic that inhibits bacterial peptidoglycan synthesis by blocking D-alanine racemase and D-Ala-D-Ala ligase, used as a second-line agent in multidrug-resistant tuberculosis regimens. Simson Pharma's Cycloserine reference standard and impurities support QC for this critical reserve TB antibiotic.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cycloserine Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.